XFOR peer analysis
X4 Pharmaceuticals (XFOR) against its competitors: price, today's move, 1-year return and market value side by side.
- XFOR's peers: ALGS (Aligos Therapeutics), INMB (INmune Bio), KPTI (Karyopharm Therapeutics), OKUR (OnKure Therapeutics), SKYE (Skye Bioscience), SNTI (Senti Biosciences), TPST (Tempest Therapeutics).
XFOR and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ALGS Aligos Therapeutics | $1.25 | -3.85% | -84.81% | $7.81M |
| INMB INmune Bio | $0.89 | -13.19% | -40.79% | $27.68M |
| KPTI Karyopharm Therapeutics | $0.02 | -56.50% | -99.68% | $394.66K |
| OKUR OnKure Therapeutics | $2.76 | -2.13% | 0.00% | $111.79M |
| SKYE Skye Bioscience | $0.79 | -23.61% | -92.49% | $3.48M |
| SNTI Senti Biosciences | $2.05 | -26.52% | -96.47% | $1.93M |
| TPST Tempest Therapeutics | $0.31 | -1.10% | -93.56% | $6.12M |
| XFOR X4 Pharmaceuticals | $3.00 | 1.35% | -17.81% | $306.34M |